טרג'נטה דואו 2.5 מג1000 מג
boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - linagliptin 2.5 mg; metformin hydrochloride 1000 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.
"implants, devices, equipment, installations, materials + accessories used for medical purposes. sterile and non-sterile."
concept for pharmacy - רופא - "implants, devices, equipment, installations, materials + accessories used for medical purposes"
גמציטבין "אבווה" 10 מ"ג/1 מ"ל
pharmalogic ltd - gemcitabine as hydrochloride 10 mg - concentrate for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.
infusion sets for sucutaneous infusion
"גפן מדיקל בע""מ" - כלל האוכלוסיה - מתקן להזרקה תת עורית
אירינוטקאן זריקות 20 מ"ג/מ"ל
novapharma ltd - irinotecan (trihydrate) hydrochloride 20 mg/ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
אירינוטקאן טבע ®
salomon,levin & elstein ltd - irinotecan hydrochloride trihydrate 20 mg / 1 ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
פלותרול
taro pharmaceutical industries ltd - fluorouracil - קרם - fluorouracil 5 %w/w - fluorouracil
גלוקופג'
abic ltd. - metformin hydrochloride - קפליות - metformin hydrochloride 850 mg - metformin
יוקריאס 501000 מג
novartis israel ltd - metformin hydrochloride; vildagliptin - טבליות מצופות פילם - metformin hydrochloride 1000 mg; vildagliptin 50 mg - metformin
יוקריאס 50500 מג
novartis israel ltd - metformin hydrochloride; vildagliptin - טבליות מצופות פילם - metformin hydrochloride 500 mg; vildagliptin 50 mg - metformin